Literature DB >> 21447101

Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients.

Margarete Niebuhr1, Annice Heratizadeh, Katja Wichmann, Imke Satzger, Thomas Werfel.   

Abstract

In many patients with atopic dermatitis (AD), the disease is complicated by their enhanced susceptibility to bacterial skin infections, especially with Staphylococcus aureus (S. aureus). Resistance to bacterial skin infections, e.g. S. aureus, is based on the function of intact innate immune mechanisms in the epidermis, mainly provided by keratinocytes. Toll-like receptor (TLR)-2 recognizes components of S. aureus and is known to be expressed on keratinocytes. The aim of this study was to investigate intrinsic TLR-2 expression and cytokine secretion upon TLR-2 stimulation with peptidoglycan (PGN), lipoteichoic acid (LTA) and N-palmitoyl-S-[2,3-bis(palmitoyl)-(2RS)-propyl]-(R)cysteinyl-alanyl-glycine (Pam3Cys) in keratinocytes from patients with AD compared to healthy controls. Human primary keratinocytes (HPKs) were cultivated from hair follicles of patients with AD and non-atopic healthy controls and stimulated with Pam3Cys, LTA and PGN. TLR-2, TLR-1 and TLR-6 expression were investigated at the mRNA level. IL-6, IL-8, chemokine C-C motif ligand (CCL)-20 and MMP-9 production were studied at the protein level. TLR-2, TLR-1 and TLR-6 were expressed on both HPKs from patients with AD as well as healthy controls without significant differences between these groups. HPKs from patients with AD had an intrinsically reduced capacity to produce IL-6, IL-8, CCL-20 and MMP-9 and responded less to TLR-2 stimulation compared to HPKs from healthy controls. Our findings show evidence for intrinsic alterations in HPKs from patients with AD compared to healthy controls and diminished responses upon TLR-2 stimulation that might contribute to the enhanced susceptibility to skin infections with S. aureus.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447101     DOI: 10.1111/j.1600-0625.2011.01277.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  10 in total

1.  MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes.

Authors:  Florian Meisgen; Ning Xu Landén; Aoxue Wang; Bence Réthi; Charbel Bouez; Michela Zuccolo; Audrey Gueniche; Mona Ståhle; Enikö Sonkoly; Lionel Breton; Andor Pivarcsi
Journal:  J Invest Dermatol       Date:  2014-02-13       Impact factor: 8.551

Review 2.  Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

3.  Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo.

Authors:  Qing Wu; Xiumei Mo; Ying Lin; Junfeng Liu; Siqi Ye; Yu Zhang; Xingxing Fan; Dacan Chen; Fenggen Yan
Journal:  Ann Transl Med       Date:  2022-09

Review 4.  Advances in atopic dermatitis.

Authors:  Natalija Novak; Donald Y M Leung
Journal:  Curr Opin Immunol       Date:  2011-10-19       Impact factor: 7.486

5.  Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis.

Authors:  Andreas Sonesson; Kornelia Przybyszewska; Sigrid Eriksson; Matthias Mörgelin; Sven Kjellström; Julia Davies; Jan Potempa; Artur Schmidtchen
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

6.  Honey is potentially effective in the treatment of atopic dermatitis: Clinical and mechanistic studies.

Authors:  Abdullah A Alangari; Keith Morris; Bashir A Lwaleed; Laurie Lau; Ken Jones; Rose Cooper; Rowena Jenkins
Journal:  Immun Inflamm Dis       Date:  2017-03-30

Review 7.  Exploring the Role of Staphylococcus Aureus Toxins in Atopic Dermatitis.

Authors:  Fabio Seiti Yamada Yoshikawa; Josenilson Feitosa de Lima; Maria Notomi Sato; Yasmin Álefe Leuzzi Ramos; Valeria Aoki; Raquel Leao Orfali
Journal:  Toxins (Basel)       Date:  2019-06-05       Impact factor: 4.546

Review 8.  Skin barrier defects in atopic dermatitis: From old idea to new opportunity.

Authors:  Takeshi Yoshida; Lisa A Beck; Anna De Benedetto
Journal:  Allergol Int       Date:  2021-12-13       Impact factor: 7.478

Review 9.  Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review.

Authors:  Peck Y Ong; Donald Y M Leung
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 10.817

Review 10.  Intracellular escape strategies of Staphylococcus aureus in persistent cutaneous infections.

Authors:  Leonie Huitema; Taylor Phillips; Vitali Alexeev; Marjana Tomic-Canic; Irena Pastar; Olga Igoucheva
Journal:  Exp Dermatol       Date:  2020-11-21       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.